Still, most experts characterize this year's newly approved women's health drugs as modest improvements rather than groundbreaking advances in medicine.
The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.
How can marketers do more with less, or otherwise convince skeptical executives that more resources will lead to long-term change?
Latesha Williams-Flynn, EVP and managing director of Concentric Health Experience, talks with Jaimy Lee, MM&M's executive editor, about the importance of taking an authentic approach to diversity in the workplace. The questions and topic were created by the MM&M editorial staff. The video is sponsored by Concentric Health Experience.
Amgen's Prolia tops the list, according to data compiled by EvaluatePharma.
The FDA declines to approve an opioid and a treatment for rheumatoid arthritis; KKR closes WebMD buyout; 60% of teens have received the HPV vaccine
The health insurance startup launched a campaign this week that urges people to get covered.
Express Scripts' Miller says new models needed to pay for CAR-T; FDA warns about Intercept drug deaths; CVS puts limits on opioid scripts
They are tasked with addressing an increasingly tough payer environment and ongoing criticism of the industry's drug-pricing practices.
Blood Equality for GMHC by FCB Health was another honoree for Ad of the Year.
Nestle to refocus Galderma's skin health R&D; Amazon is reportedly in talks with PBMs; most Americans do not actively read science news
Beyond providing access, co-pay cards represent a starting point to more powerful patient engagement.
A "seat at the table" isn't enough, says Oath's Allison Allen, in wide-ranging discussion at annual diversity conference.
Facebook itself has more than six million health-related groups.
Pfizer sues J&J over Remicade contracts; drugmakers trim sales forces for rare-disease drugs; Roche's oncology business under siege from biosimilars
Exact Sciences has found success by marketing Cologuard in ads airing on networks like MSNBC, CNN, and Fox News.
Only three of the seven FDA-approved biosimilars are available for sale; Teva to sell off women's health portfolio; the FDA approves GSK's COPD combo
The new brand campaign, Attacking Cancer from Every Angle, showcases all the services the organization provides.
The company also this year has purchased Vynamic and Cambridge BioMarketing.